Summary:
We investigated the changes in sexual function in male patients with germ cell tumor continuously disease free after one or two courses of high-dose chemotherapy with hematopoietic stem cell support. A questionnaire was mailed to 35 patients, and 30 patients sent it back. Sexuality was considered a problem by 10 patients (33%), but no patients considered sexuality a major problem. Erection was more difficult to achieve in seven patients (23%) and 10 patients (33%) experienced increased difficulty in maintaining an erection. Eight patients (27%) had the experience of less intensive and less frequent orgasm. In all, 13 patients (43%) thought that both the disease and treatment had worsened their sexual capacity, but 20 patients (67%) were satisfied with their sex life. Most of the patients (63%) considered that insufficient information and counselling had been given by their physicians about the sexual sequelae of therapy. However, the amount of information about the disease and treatment was considered good by 77 and 80% of the patients, respectively. This study shows that 27% of patients were not content with their ability to attain sexual satisfaction due to the illness or its treatment. Communication is an important issue and better information tools could lead to improved compliance in these patients.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
van Basten JPA, Hoekstra HJ, van Driel H et al. Sexual dysfunction in nonseminoma testicular cancer patients is related to chemotherapy-induced angiopathy. J Clin Oncol 1997; 15: 2442–2448.
Molassiotis A, van den Akker OB, Milligan DW et al. Gonadal function and psychosexual adjustment in male long-term survivors of bone marrow transplantation. Bone Marrow Transplant 1995; 16: 253–259.
Syrjala KL, Roth-Roemer SL, Abrams JR et al. Prevalence and predictors of sexual dysfunction in long-term survivors of marrow transplantation. J Clin Oncol 1998; 16: 3148–3157.
Chao NJ, Tierney K, Bloom JR et al. Dynamic assessment of quality of life after autologous bone marrow transplantation. Blood 1992; 80: 825–830.
Vose JM, Kennedy BC, Bierman PJ et al. Long-term sequelae of autologous bone marrow or peripheral stem cell transplantation for lymphoid malignancies. Cancer 1992; 69: 784–789.
Marks DI, Crilley P, Nezu CM et al. Sexual dysfunction prior to high-dose chemotherapy and bone marrow transplantation. Bone Marrow Transplant 1996; 17: 595–599.
Anderson BL . How cancer affects sexual functioning. Oncology 1990; 4: 81–82.
Litwin MS, Hays RD, Fink A et al. Quality of life outcomes in men treated for localized prostate cancer. JAMA 1995; 273: 129–135.
Jonker-Pool G, van Basten JP, Hoekstra HJ et al. Sexual functioning after treatment for testicular cancer. Comparison of treatment modalities. Cancer 1997; 80: 454–464.
Guillemin F, Bombardier C, Beaton D . Cross-cultural adaptation of health-related quality of life measures: literature review and proposed guidelines. J Clin Epidemiol 1993; 46: 1417–1432.
Bosl GJ, Moetzer RJ . Testicular germ-cell cancer. N Engl J Med 1997; 337: 242–253.
van Basten JPA, van Driel MF, Hoekstra HJ et al. Objective and subjective effects of treatment for testicular cancer on sexual function. Br J Urol Intern 1999; 84: 671–678.
De Giorgi U, Rosti G, Papiani G, Marangolo M . The status of high-dose chemotherapy with hematopoietic stem cell transplantation in patients with germ cell tumor. Haematologica 2002; 87: 95–104.
Hjermstad MJ, Holte H, Evensen SA et al. Do patients who are treated with stem cell transplantation have a health-related quality of life comparable to the general population after 1 year? Bone Marrow Transplant 1999; 24: 911–918.
Marks DI, Friedman SH, Delli Carpini L et al. A prospective study of the effects of high-dose chemotherapy and bone marrow transplantation on sexual function in the first year after transplant. Bone Marrow Transplant 1997; 19: 819–822.
Arai Y, Kawakita M, Hida S et al. Psychosocial aspects in long-term survivors of testicular cancer. J Urol 1996; 155: 574–578.
Rieker PP, Fitzgerald EM, Kalish LA et al. Psychological factors, curative therapies, and behavioral outcomes. A comparison of testis cancer survivors and control group of healthy men. Cancer 1989; 64: 2399–2407.
Stoter G, Koopman A, Vendrik CPJ et al. Ten-years survival and late sequelae in testicular cancer patients treated with cisplatin, vinblastine and bleomycin. J Clin Oncol 1989; 7: 1099–1104.
Gritz ER, Wellisch DK, Wang HJ et al. Long-term effects of testicular cancer on sexual functioning in married couple. Cancer 1989; 64: 1560–1567.
Bloom JR, Fobair P, Gritz E et al. Psychosocial outcomes of cancer: a comparative analysis of Hodgkin's disease and testicular cancer. J Clin Oncol 1993; 11: 979–988.
van Basten JP, Jonker-Pool G, van Driel MF et al. Fantasies and facts of the testes. Br J Urol 1996; 78: 756–762.
Acknowledgements
We are indebted to Dr Orazio Caffo from Department of Medical Oncology, Santa Chiara Hospital, Trento (Italy) for providing the questionnaire, Professor Adriana Montebelli for reviewing the manuscript and all the patients who agreed to take part in this survey. This study was supported by Istituto Oncologico Romagnolo.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Monti, M., Rosti, G., Giorgi, U. et al. Sexual functions after high-dose chemotherapy in survivors of germ cell tumors. Bone Marrow Transplant 32, 933–939 (2003). https://doi.org/10.1038/sj.bmt.1704256
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1704256